These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 3289152)
1. Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo. Auchincloss H; Ghobrial RR; Russell PS; Winn HJ Transplantation; 1988 Jun; 45(6):1118-23. PubMed ID: 3289152 [TBL] [Abstract][Full Text] [Related]
2. Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48. Yang TY; Sun Y; Langnas AN; Zhao Y Clin Immunol; 2003 Feb; 106(2):148-54. PubMed ID: 12672405 [TBL] [Abstract][Full Text] [Related]
3. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft. Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264 [TBL] [Abstract][Full Text] [Related]
4. Comparison of GK1.5 and chimeric rat/mouse GK1.5 anti-CD4 antibodies for prolongation of skin allograft survival and suppression of alloantibody production in mice. Rashid A; Auchincloss H; Sharon J J Immunol; 1992 Mar; 148(5):1382-8. PubMed ID: 1538121 [TBL] [Abstract][Full Text] [Related]
5. Rejection of skin grafts and generation of cytotoxic T cells by mice depleted of L3T4+ cells. Woodcock J; Wofsy D; Eriksson E; Scott JH; Seaman WE Transplantation; 1986 Dec; 42(6):636-42. PubMed ID: 2947360 [TBL] [Abstract][Full Text] [Related]
6. Role of CD4+ T cells in the rat to mouse cardiac xenotransplantation. Matsumiya G; Shirakura R; Miyagawa S; Izutani H; Nakata S; Shimazaki Y; Nakano S; Matsuda H Transpl Int; 1994; 7 Suppl 1():S654-9. PubMed ID: 11271332 [TBL] [Abstract][Full Text] [Related]
7. Two levels of help for B cell alloantibody production. Steele DJ; Laufer TM; Smiley ST; Ando Y; Grusby MJ; Glimcher LH; Auchincloss H J Exp Med; 1996 Feb; 183(2):699-703. PubMed ID: 8627185 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppression by anti-CD4 treatment in vivo. Cellular and humoral responses to alloantigens. Weyand CM; Goronzy J; Swarztrauber K; Fathman CG Transplantation; 1989 Jun; 47(6):1039-42. PubMed ID: 2472024 [TBL] [Abstract][Full Text] [Related]
9. Induction of immune tolerance during administration of monoclonal antibody to L3T4 does not depend on depletion of L3T4+ cells. Carteron NL; Wofsy D; Seaman WE J Immunol; 1988 Feb; 140(3):713-6. PubMed ID: 2448372 [TBL] [Abstract][Full Text] [Related]
10. Transgenic anti-CD4 monoclonal antibody secretion by mouse segmental pancreas allografts promotes long term survival. Mottram PL; Murray-Segal LJ; Han W; Zhan Y; Brady JL; Lew AM Transpl Immunol; 2000 Nov; 8(3):203-9. PubMed ID: 11147701 [TBL] [Abstract][Full Text] [Related]
11. The effect of idarubicin monoclonal antibody treatment of first-set rejection of murine skin allografts. Smyth MJ; McKenzie IF; Pietersz GA Transplantation; 1989 Jul; 48(1):77-9. PubMed ID: 2665240 [TBL] [Abstract][Full Text] [Related]
12. L3T4+ T-cell-independent reactivity of Lyt2+ T cells in vivo. Heeg K; Steeg C; Wagner H Cell Immunol; 1988 Jan; 111(1):148-57. PubMed ID: 2962740 [TBL] [Abstract][Full Text] [Related]
13. Highly disparate xenogeneic skin graft tolerance induction by fetal pig thymus in thymectomized mice: Conditioning requirements and the role of coimplantation of fetal pig liver. Zhao Y; Rodriguez-Barbosa JI; Swenson K; Zhao G; Arn JS; Sykes M Transplantation; 2001 Nov; 72(10):1608-15. PubMed ID: 11726819 [TBL] [Abstract][Full Text] [Related]
14. Treatment of murine lupus with F(ab')2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion. Carteron NL; Schimenti CL; Wofsy D J Immunol; 1989 Mar; 142(5):1470-5. PubMed ID: 2521880 [TBL] [Abstract][Full Text] [Related]
15. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells. Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230 [TBL] [Abstract][Full Text] [Related]
16. Effector cells in allelic H-2 class I-incompatible skin graft rejection. Ichikawa T; Nakayama E; Uenaka A; Monden M; Mori T J Exp Med; 1987 Oct; 166(4):982-90. PubMed ID: 3309129 [TBL] [Abstract][Full Text] [Related]
17. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen. Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930 [TBL] [Abstract][Full Text] [Related]
18. Role of the L3T4+ T cell in allograft rejection. Hao L; Wang Y; Gill RG; Lafferty KJ J Immunol; 1987 Dec; 139(12):4022-6. PubMed ID: 3121726 [TBL] [Abstract][Full Text] [Related]
19. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts. Smith DM; Stuart FP; Wemhoff GA; Quintáns J; Fitch FW Transplantation; 1988 Jan; 45(1):168-75. PubMed ID: 3276046 [TBL] [Abstract][Full Text] [Related]
20. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection. Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]